|
1
|
Silva MVF, Loures CMG, Alves LCV, de Souza
LC, Borges KBG and Carvalho MDG: Alzheimer's disease: Risk factors
and potentially protective measures. J Biomed Sci. 26:332019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemimah S, Chabib CMM, Hadjileontiadis L
and AlShehhi A: Gut microbiome dysbiosis in Alzheimer's disease and
mild cognitive impairment: A systematic review and meta-analysis.
PLoS One. 18:e02853462023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jack CR Jr, Bennett DA, Blennow K,
Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen
F, Karlawish J, et al: NIA-AA research framework: Toward a
biological definition of Alzheimer's disease. Alzheimers Dement.
14:535–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jack CR Jr, Andrews JS, Beach TG,
Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E,
et al: Revised criteria for diagnosis and staging of Alzheimer's
disease: Alzheimer's association workgroup. Alzheimers Dement.
20:5143–5169. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Shi Z, Qiu Y, Sun D and Zhou H:
Peripheral GFAP and NfL as early biomarkers for dementia:
Longitudinal insights from the UK Biobank. BMC Med. 22:1922024.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chatterjee P, Pedrini S, Doecke JD, Thota
R, Villemagne VL, Doré V, Singh AK, Wang P, Rainey-Smith S, Fowler
C, et al: Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the
Alzheimer's disease continuum: A cross-sectional and longitudinal
study in the AIBL cohort. Alzheimers Dement. 19:1117–1134. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y,
Liu Q, Hoffmann PR, Ni JZ and Song GL: Selenomethionine mitigates
cognitive decline by targeting both tau hyperphosphorylation and
autophagic clearance in an Alzheimer's disease mouse model. J
Neurosci. 37:2449–2462. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Au NPB and Ma CHE: Neuroinflammation,
microglia and implications for retinal ganglion cell survival and
axon regeneration in traumatic optic neuropathy. Front Immunol.
3:8600702022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nava Catorce M, Acero G and Gevorkian G:
Age- and sex-dependent alterations in the peripheral immune system
in the 3×Tg-AD mouse model of Alzheimer's disease: Increased
proportion of CD3+CD4-CD8- double-negative T cells in the blood. J
Neuroimmunol. 360:5777202021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taoka T, Masutani Y, Kawai H, Nakane T,
Matsuoka K, Yasuno F, Kishimoto T and Naganawa S: Evaluation of
glymphatic system activity with the diffusion MR technique:
diffusion tensor image analysis along the perivascular space
(DTI-ALPS) in Alzheimer's disease cases. Jpn J Radiol. 35:172–178.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Piehl N, van Olst L, Ramakrishnan A,
Teregulova V, Simonton B, Zhang Z, Tapp E, Channappa D, Oh H,
Losada PM, et al: Cerebrospinal fluid immune dysregulation during
healthy brain aging and cognitive impairment. Cell.
185:5028–5039.e13. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jorfi M, Park J, Hall CK, Lin CJ, Chen M,
von Maydell D, Kruskop JM, Kang B, Choi Y, Prokopenko D, et al:
Infiltrating CD8(+) T cells exacerbate Alzheimer's disease
pathology in a 3D human neuroimmune axis model. Nat Neurosci.
26:1489–1504. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bettcher BM, Tansey MG, Dorothée G and
Heneka MT: Peripheral and central immune system crosstalk in
Alzheimer disease - a research prospectus. Nat Rev Neurol.
17:689–701. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Demir SA, Timur ZK, Ateş N, Martínez LA
and Seyrantepe V: GM2 ganglioside accumulation causes
neuroinflammation and behavioral alterations in a mouse model of
early onset Tay-Sachs disease. J Neuroinflammation. 17:2772020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Serrano-Pozo A, Das S and Hyman BT: APOE
and Alzheimer's disease: Advances in genetics, pathophysiology, and
therapeutic approaches. Lancet Neurol. 20:68–80. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cummings J, Apostolova L, Rabinovici GD,
Atri A, Aisen P, Greenberg S, Hendrix S, Selkoe D, Weiner M,
Petersen RC and Salloway S: Lecanemab: Appropriate Use
Recommendations. J Prev Alzheimers Dis. 10:362–377. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weinstein JD: A new direction for
Alzheimer's research. Neural Regen Res. 13:190–193. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Srinivasan K, Friedman BA, Etxeberria A,
Huntley MA, van der Brug MP, Foreman O, Paw JS, Modrusan Z, Beach
TG, Serrano GE and Hansen DV: Alzheimer's patient microglia exhibit
enhanced aging and unique transcriptional activation. Cell Rep.
31:1078432020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie Y, Shi H and Han B: Bioinformatic
analysis of underlying mechanisms of Kawasaki disease via Weighted
gene correlation network analysis (WGCNA) and the Least absolute
shrinkage and selection operator method (LASSO) regression model.
BMC Pediatr. 23:902023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Uddin S, Khan A, Hossain ME and Moni MA:
Comparing different supervised machine learning algorithms for
disease prediction. BMC Med Inform Decis Mak. 19:2812019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yi F, Yang H, Chen D, Qin Y, Han H, Cui J,
Bai W, Ma Y, Zhang R and Yu H: XGBoost-SHAP-based interpretable
diagnostic framework for alzheimer's disease. BMC Med Inform Decis
Mak. 23:1372023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Greener JG, Kandathil SM, Moffat L and
Jones DT: A guide to machine learning for biologists. Nat Rev Mol
Cell Biol. 23:40–55. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Robin X, Turck N, Hainard A, Tiberti N,
Lisacek F, Sanchez JC and Müller M: pROC: An open-source package
for R and S+ to analyze and compare ROC curves. BMC Bioinformatics.
12:772011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McCarthy MM: Multifaceted origins of sex
differences in the brain. Philos Trans R Soc Lond B Biol Sci.
371:201501062016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Souza LC, Filho CB, Goes AT, Fabbro LD, de
Gomes MG, Savegnago L, Oliveira MS and Jesse CR: Neuroprotective
effect of physical exercise in a mouse model of Alzheimer's disease
induced by β-amyloid1-4o peptide. Neurotox Res.
24:148–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cioanca O, Hancianu M, Mihasan M and
Hritcu L: Anti-acetylcholinesterase and antioxidant activities of
inhaled juniper oil on amyloid beta (1–42)-induced oxidative stress
in the rat hippocampus. Neurochem Res. 40:952–960. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chambon C, Wegener N, Gravius A and Danysz
W: Behavioural and cellular effects of exogenous amyloid-β peptides
in rodents. Behav Brain Res. 225:623–641. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Souza LC, Jesse CR, Antunes MS, Ruff JR,
de Oliveira Espinosa D, Gomes NS, Donato F, Giacomeli R and Boeira
SP: Indoleamine-2,3-dioxygenase mediates neurobehavioral
alterations induced by an intracerebroventricular injection of
amyloid-β1-42 peptide in mice. Brain Behav Immun. 56:363–377. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McKhann GM, Knopman DS, Chertkow H, Hyman
BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux
R, et al: The diagnosis of dementia due to Alzheimer's disease:
Recommendations from the National Institute on Aging-Alzheimer's
Association workgroups on diagnostic guidelines for Alzheimer's
disease. Alzheimers Dement. 7:263–269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X and Ishwaran H: Random forests for
genomic data analysis. Genomics. 99:323–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Golde TE: Alzheimer's disease - the
journey of a healthy brain into organ failure. Mol Neurodegener.
17:182022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Novoa C, Salazar P, Cisternas P,
Gherardelli C, Vera-Salazar R, Zolezzi JM and Inestrosa NC:
Inflammation context in Alzheimer's disease, a relationship
intricate to define. Biol Res. 55:392022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Johnson AM and Lukens JR: The innate
immune response in tauopathies. Eur J Immunol. 53:e22502662023.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo R and Yu JT: New biomarkers for
early-stage tau pathology in Alzheimer's disease. Nat Aging.
5:734–735. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hajian-Tilaki K: Receiver operating
characteristic (ROC) curve analysis for medical diagnostic test
evaluation. Caspian J Intern Med. 4:627–635. 2013.PubMed/NCBI
|
|
40
|
Saaoud F, Liu L, Xu K, Lu Y, Shao Y, Ben
Issa M, Jiang X, Wang X, Liu X, Autieri M, et al: Alzheimer's
disease as an auto-innate immune pathology with potential cell
trans-differentiation and enhanced trained immunity in 3×Tg-AD
mouse model. J Alzheimers Dis. 105:550–572. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Heppner FL, Ransohoff RM and Becher B:
Immune attack: The role of inflammation in Alzheimer disease. Nat
Rev Neurosci. 16:358–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Korte N, Barkaway A, Wells J, Freitas F,
Sethi H, Andrews SP, Skidmore J, Stevens B and Attwell D:
Inhibiting Ca(2+) channels in Alzheimer's disease model mice
relaxes pericytes, improves cerebral blood flow and reduces immune
cell stalling and hypoxia. Nat Neurosci. 27:2086–2100. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zieneldien T, Kim J, Sawmiller D and Cao
C: The immune system as a therapeutic target for Alzheimer's
disease. Life (Basel). 12:14402022.PubMed/NCBI
|
|
44
|
Yang F, Zhang N, Ou GY and Xu SW:
integrated bioinformatic analysis and validation identifies immune
microenvironment-related potential biomarkers in Alzheimer's
disease. J Prev Alzheimers Dis. 11:495–506. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xu L, Li L, Pan CL, Song JJ, Zhang CY, Wu
XH, Hu F, Liu X, Zhang Z and Zhang ZY: Erythropoietin signalling in
peripheral macrophages is required for systemic β-amyloid
clearance. EMBO J. 41:e1110382022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang S, Gao Y, Zhao Y, Huang TY, Zheng Q
and Wang X: Peripheral and central neuroimmune mechanisms in
Alzheimer's disease pathogenesis. Mol Neurodegener. 20:222025.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dai L and Shen Y: Insights into T-cell
dysfunction in Alzheimer's disease. Aging Cell. 20:e135112021.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen Y, Dai J, Tang L, Mikhailova T, Liang
Q, Li M, Zhou J, Kopp RF, Weickert C, Chen C and Liu C: Neuroimmune
transcriptome changes in patient brains of psychiatric and
neurological disorders. Mol Psychiatry. 28:710–721. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ding F, Su CJ, Edmonds KK, Liang G and
Elowitz MB: Dynamics and functional roles of splicing factor
autoregulation. Cell Rep. 39:1109852022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhu GQ, Tang Z, Chu TH, Wang B, Chen SP,
Tao CY, Cai JL, Yang R, Qu WF, Wang Y, et al: Targeting SRSF1
improves cancer immunotherapy by dually acting on CD8(+)T and tumor
cells. Signal Transduct Target Ther. 10:252025. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bowles KR, Pugh DA, Oja LM, Jadow BM,
Farrell K, Whitney K, Sharma A, Cherry JD, Raj T, Pereira AC, et
al: Dysregulated coordination of MAPT exon 2 and exon 10 splicing
underlies different tau pathologies in PSP and AD. Acta
Neuropathol. 143:225–243. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
van Bergeijk P, Seneviratne U,
Aparicio-Prat E, Stanton R and Hasson SA: SRSF1 and PTBP1 are
trans-acting factors that suppress the formation of a CD33 splicing
isoform linked to Alzheimer's disease risk. Mol Cell Biol.
39:e00568–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Eskandari-Sedighi G, Crichton M, Zia S,
Gomez-Cardona E, Cortez LM, Patel ZH, Takahashi-Yamashiro K, St
Laurent CD, Sidhu G, Sarkar S, et al: Alzheimer's disease
associated isoforms of human CD33 distinctively modulate microglial
cell responses in 5XFAD mice. Mol Neurodegener. 19:422024.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cassidy MF, Herbert ZT and Moulton VR:
Splicing factor SRSF1 controls distinct molecular programs in
regulatory and effector T cells implicated in systemic autoimmune
disease. Mol Immunol. 141:94–103. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Paz S, Ritchie A, Mauer C and Caputi M:
The RNA binding protein SRSF1 is a master switch of gene expression
and regulation in the immune system. Cytokine Growth Factor Rev.
57:19–26. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Panwar V, Singh A, Bhatt M, Tonk RK,
Azizov S, Raza AS, Sengupta S, Kumar D and Garg M: Multifaceted
role of mTOR (mammalian target of rapamycin) signalling pathway in
human health and disease. Signal Transduct Target Ther. 8:3752023.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Huang G, Shi LZ and Chi H: Regulation of
JNK and p38 MAPK in the immune system: signal integration,
propagation and termination. Cytokine. 48:161–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Winter JN, Jefferson LS and Kimball SR:
ERK and Akt signalling pathways function through parallel
mechanisms to promote mTORC1 signalling. Am J Physiol Cell Physiol.
300:C1172–C1180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Fu X, Xu M, Zhang H, Li Y, Li Y and Zhang
C: Staphylococcal enterotoxin C2 mutant-directed fatty acid and
mitochondrial energy metabolic programs regulate CD8(+) T cell
activation. J Immunol. 205:2066–2076. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Goel P, Chakrabarti S, Goel K, Bhutani K,
Chopra T and Bali S: Neuronal cell death mechanisms in Alzheimer's
disease: An insight. Front Mol Neurosci. 15:9371332022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Muñoz-Ballester C and Robel S:
Astrocyte-mediated mechanisms contribute to traumatic brain injury
pathology. WIREs Mech Dis. 15:e16222023. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Shen XN, Huang SY, Cui M, Zhao QH, Guo Y,
Huang YY, Zhang W, Ma YH, Chen SD, Zhang YR, et al: Plasma glial
fibrillary acidic protein in the Alzheimer disease continuum:
Relationship to other biomarkers, differential diagnosis, and
prediction of clinical progression. Clin Chem. 69:411–421. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Janelidze S, Stomrud E, Smith R, Palmqvist
S, Mattsson N, Airey DC, Proctor NK, Chai X, Shcherbinin S, Sims
JR, et al: Cerebrospinal fluid p-tau217 performs better than
p-tau181 as a biomarker of Alzheimer's disease. Nat Commun.
11:16832020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang J, Huang S, Lan G, Lai YJ, Wang QH,
Chen Y, Xiao ZS, Chen X, Bu XL, Liu YH, et al: Diagnostic accuracy
of plasma p-tau217/Abeta42 for Alzheimer's disease in clinical and
community cohorts. Alzheimers Dement. 21:e700382025. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Apicco DJ, Zhang C, Maziuk B, Jiang L,
Balance HI, Boudeau S, Ung C, Li H and Wolozin B: Dysregulation of
RNA splicing in tauopathies. Cell Rep. 29:4377–4388.e4. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Pan Y and Monje M: Neuron-Glial
interactions in health and brain cancer. Adv Biol (Weinh).
6:e22001222022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
De I, Maklakova V, Litscher S, Boyd MM,
Klemm LC, Wang Z, Kendziorski C and Collier LS: Microglial
responses to CSF1 overexpression do not promote the expansion of
other glial lineages. J Neuroinflammation. 18:1622021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Su S, Katopodi XL, Pita-Juarez YH,
Maverakis E, Vlachos IS and Adamopoulos IE: Serine and arginine
rich splicing factor 1 deficiency alters pathways involved in
IL-17A expression and is implicated in human psoriasis. Clin
Immunol. 240:1090412022. View Article : Google Scholar : PubMed/NCBI
|
